Contrastingly, Frühbeck et al. demonstrated significant reduced circulating kallistatin in human obesity, and SERPINA4 gene expression levels were downregulated in the liver of obese patients with NAFLD (47). Here, SERPINA4 is linked to metabolic dysfunction-associated steatotic liver disease.